Clinical Trial Update: Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update reports results from evaluating the combination of sirolimus and auranofin in patients with advanced or recurrent non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Auranofin (auranofin)
• Rapamycin (sirolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-20